Shares of Microbix Biosystems Inc. (TSE:MBX – Get Free Report) traded up 3% on Wednesday . The stock traded as high as C$0.35 and last traded at C$0.35. 6,000 shares changed hands during mid-day trading, a decline of 90% from the average session volume of 62,532 shares. The stock had previously closed at C$0.34.
Microbix Biosystems Price Performance
The company has a market cap of C$49.47 million, a P/E ratio of 11.17 and a beta of 0.25. The company’s 50-day moving average price is C$0.32 and its two-hundred day moving average price is C$0.35. The company has a current ratio of 8.53, a quick ratio of 5.57 and a debt-to-equity ratio of 24.53.
Microbix Biosystems Company Profile
Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.
Featured Stories
- Five stocks we like better than Microbix Biosystems
- How to Invest in the FAANG Stocks
- Defying the Market: 3 Mega-Cap Stocks Soaring to New Highs
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Microsoft Stock: Is Now The Time To Be Greedy?
- What is the Australian Securities Exchange (ASX)
- How to Invest in Mutual Funds
Receive News & Ratings for Microbix Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbix Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
